【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
• Key buying criteria
PART 05: Cardiovascular drugs market
• Global pharmaceuticals market
• Global cardiovascular drugs market
PART 06: Overview: Hypertension
• Systemic hypertension
• PAH
PART 07: Epidemiology and economic burden
• Economic burden
PART 08: Pipeline portfolio
PART 09: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 10: Market segmentation by type
• Global systemic hypertension drugs market
• Global PAH drugs market
PART 11: Market segmentation by drug class
• Systemic hypertension
• PAH
PART 12: Geographical segmentation
• Global hypertension drugs market by geographical segmentation 2015-2020
• Hypertension drugs market in Americas
• Hypertension drugs market in EMEA
• Hypertension drugs market in APAC
PART 13: Market drivers
• Growing older population
• Rise in sedentary lifestyle
• High prevalence of chronic conditions
• Patient assistance programs
PART 14: Impact of drivers
PART 15: Market challenges
• Patent expiries of major drugs
• Adverse effects
• Poor patient compliance
• Availability of alternative therapies
PART 16: Impact of drivers and challenges
PART 17: Market trends
• Increase in awareness
• Increased focus on combination therapies
• Intense competition among vendors
• Strategic alliances
PART 18: Vendor landscape
• Competitive scenario
• Market share 2015
• Novartis
• Daiichi Sankyo
• Actelion Pharmaceuticals
• Boehringer Ingelheim
• Sanofi
• AstraZeneca
• Other prominent vendors
PART 19: Appendix
• List of abbreviations
PART 20: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Key buying criteria for drugs that treat hypertension
Exhibit 03: Patent expiries of major cardiovascular drugs
Exhibit 04: Global cardiovascular drugs market by generic and branded drugs sales 2015
Exhibit 05: Top 10 companies in global cardiovascular drugs market 2014
Exhibit 06: Pathophysiology of hypertension
Exhibit 07: Treatment algorithm for hypertension
Exhibit 08: Prevalence of PAH by cause
Exhibit 09: Projected prevalence of CVDs in US 2010-2030 (% of population)
Exhibit 10: Prevalence of hypertension in US population 2010-2030 (% of population)
Exhibit 11: Projected direct and indirect burden of hypertension in US 2010-2030 ($ billions)
Exhibit 12: Projected mortality trend for CVDs globally 2015 and 2030
Exhibit 13: Pipeline portfolio: Global systemic hypertension drugs
Exhibit 14: Pipeline portfolio: Global PAH drugs
Exhibit 15: Market share of global hypertension drugs in global pharmaceutical market 2015
Exhibit 16: Global hypertension drugs market 2015-2020 ($ billions)
Exhibit 17: Five forces analysis
Exhibit 18: Global hypertension drugs market segmentation by type 2015
Exhibit 19: Global systemic hypertension drugs market 2015-2020 ($ billions)
Exhibit 20: Global PAH drugs market 2015-2020 ($ billions)
Exhibit 21: Segmentation of global hypertension drugs market by drug class
Exhibit 22: Global systemic hypertension drugs market share by drug class 2015
Exhibit 23: Global PAH drugs market share by drug class 2015
Exhibit 24: Segmentation of global hypertension drugs market based on geography 2015
Exhibit 25: Hypertension drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 26: Percentage share of hypertension drugs market by geography 2015-2020
Exhibit 27: Hypertension drugs market in Americas 2015-2020 ($ billions)
Exhibit 28: Hypertension drugs market in EMEA 2015-2020 ($ billions)
Exhibit 29: Hypertension drugs market in APAC 2015-2020 ($ billions)
Exhibit 30: Global hypertension drugs market: YoY growth rate and revenue based on geography 2015-2020
Exhibit 31: Population aged 60 years and over: World, developed, and developing regions ($ millions)
Exhibit 32: Impact of drivers
Exhibit 33: Impact of drivers and challenges
Exhibit 34: Sales of major drugs in global hypertension drugs market 2014 ($ billions)
Exhibit 35: Novartis: YoY growth rate and revenue of Diovan 2012-2015 ($ billions)
Exhibit 36: Novartis: YoY growth rate and revenue of Exforge 2012-2015 ($ billions)
Exhibit 37: Novartis: Key takeaways
Exhibit 38: Daiichi Sankyo: YoY growth rate and revenue of Olmetec in Japan 2012-2014 ($ millions)
Exhibit 39: Daiichi Sankyo: YoY growth rate and revenue of Olmetec/Olmetec Plus in Europe 2012-2014 ($ millions)
Exhibit 40: Daiichi Sankyo: YoY growth rate and revenue of Rezaltas in Japan 2012-2014 ($ millions)
Exhibit 41: Daiichi Sankyo: YoY growth rate and revenue of Artist in Japan 2012-2014 ($ millions)
Exhibit 42: Daiichi Sankyo: YoY growth rate and revenue of Benicar/Benicar HCT in US 2012-2014 ($ millions)
Exhibit 43: Daiichi Sankyo: YoY growth rate and revenue of AZOR in US 2012-2014 ($ millions)
Exhibit 44: Daiichi Sankyo: YoY growth rate and revenue of TRIBENZOR in US 2012-2014 ($ millions)
Exhibit 45: Daiichi Sankyo: YoY growth rate and revenue of Sevikar in Europe 2012-2014 ($ millions)
Exhibit 46: Daiichi Sankyo: YoY growth rate and revenue of Sevikar HCT in Europe 2012-2014 ($ millions)
Exhibit 47: Daiichi Sankyo: Key takeaways
Exhibit 48: Actelion Pharmaceuticals: YoY growth rate and revenue of Tracleer 2011-2014 ($ billions)
Exhibit 49: Actelion Pharmaceuticals: YoY revenue of Opsumit 2013 and 2014 ($ millions)
Exhibit 50: Actelion Pharmaceuticals: YoY growth rate and revenue of Ventavis 2011-2014 ($ millions)
Exhibit 51: Actelion Pharmaceuticals: YoY growth rate and revenue of Veletri 2011-2014 ($ millions)
Exhibit 52: Actelion Pharmaceuticals: Key takeaways
Exhibit 53: Boehringer Ingelheim: YoY growth rate and revenue of Micardis 2012-2014 ($ millions)
Exhibit 54: Boehringer Ingelheim: Key takeaways
Exhibit 55: Sanofi: YoY growth rate and revenue of Aprovel 2012-2014 ($ millions)
Exhibit 56: Sanofi: YoY growth rate and revenue of Tritace 2012-2014 ($ millions)
Exhibit 57: Sanofi: YoY growth rate and revenue of Lasix 2012-2014 ($ millions)
Exhibit 58: Sanofi: Key takeaways
Exhibit 59: AstraZeneca: Business segmentation by revenue 2015
Exhibit 60: AstraZeneca: YoY growth rate and revenue of Seloken/Toprol 2013-2015 ($ millions)
Exhibit 61: AstraZeneca: YoY growth rate and revenue of Atacand 2013-2015 ($ millions)
Exhibit 62: AstraZeneca: YoY growth rate and revenue of Tenormin 2012-2014 ($ millions)
Exhibit 63: AstraZeneca: Key takeaways
【レポート販売概要】
■ タイトル:高血圧治療薬の世界市場2016-2020■ 英文:Global Hypertension Drugs Market 2016-2020
■ 発行日:2016年4月13日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9233
■ 調査対象地域:グローバル
- IPaaSの世界市場2015-2019About iPaaS iPaaS is a cloud integration platform that integrates application and database. Various activities such as development, execution, and governance of integration process among on-premises or cloud-based applications are taken care of by iPaaS solution. An iPaaS solution includes batch and real-time integration services, API framework, MDM, data quality, and security measures. Most iPaaS …
- 世界のプロジェクトポートフォリオ管理市場:コンポーネント別(ソリューション&サービス)、組織規模別、展開モード別、業種別(エネルギー&ユーティリティ、政府&防衛、製造、ヘルスケア&ライフサイエンス)、地域別Growing demand for cloud-based PPM solution to gain a birds view on project operations and resource management are expected to drive the growth of the PPM market The global Project Portfolio Management (PPM) market size is expected to grow from USD 4.0 billion in 2019 to USD 5.6 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.9% during the forecast period. The PPM market is driven by …
- 転移性腎細胞がん(Metastatic Renal Cell Carcinoma)の治療薬パイプライン動向(2015年上半期版)Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Metastatic Renal Cell Carcinoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Renal Cell Carcinoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Metastatic Renal Cell Carcinoma, complete with comparative analysis at various s …
- 航空保険の世界市場2016-2020:サービスプロバイダー、空港運営者About Aerospace Insurance Aerospace insurance, as covered in this report, encompasses the insurance policies designed for airlines, airports and their operations, as well as other aviation service providers. Aerospace is one of the biggest sectors worldwide responsible for the conveyance of a growing number of passengers and cargo. Technavio’s analysts forecast the global aerospace insurance marke …
- 医療用レーザーの世界市場:製品種類別(固体レーザーシステム、ガスレーザーシステム、色素レーザーシステム、ダイオードレーザーシステム)、用途別(眼科、皮膚科、婦人科、歯科、泌尿器科、心臓血管、その他)、エンドユーザー別(外科、化粧品、歯科)The global medical laser market size was valued at $6,947 million in 2018, and is projected to reach $16,230 million by 2026, growing at a CAGR of 10.8% from 2019-2026. Laser stands for light amplification by stimulated emission of radiation, which has a specific wavelength creating high-intensity light. The adoption of medical lasers has increased due to its diverse medical applications including …
- Talisman Energy Inc.:石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Talisman Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source f …
- 研究開発アウトソーシングのグローバル市場動向(2014-2018)About Global R&D Outsourcing Market R&D Outsourcing refers to the outsourcing of specific R&D services to third-party service providers such as designing, prototyping, testing, and manufacturing and sales. Though R&D services are a critical part of any vertical, the recent economic downturn and the need to survive in extremely competitive market environments has forced organizations to outsource t …
- Epic Energy:石油・ガスバリューチェーン分析レポート2013Epic Energy Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Epic Energy" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Epic Energy”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
- 免疫組織化学の世界市場2019-2023About this market The continuously increasing aging population is one of the key factors expected to trigger the market’s growth in the forthcoming years. The aging population is vulnerable to several infectious diseases and has a high risk of health complications, thus, driving the immunohistochemistry market growth. Furthermore, the rising aging population has also contributed to increased expen …
- 空気輸送システムの世界市場:動作原理別(希薄相、濃密相)、技術別(陽圧システム、真空システム)、最終用途別、セグメント予測The global pneumatic conveying systems market size is expected to reach USD 36.5 billion by 2025, according to a study conducted by Grand View Research, Inc., expanding at a CAGR of 5.7% during the forecast period. Rise in prominence of automation in the manufacturing industry in recent years has positively influenced the market for conveying systems and material handling equipment. There has also …
- 世界の歯科インプラント市場動向(2012-2016)TechNavio's analysts forecast the Global Dental Implants market to grow at a CAGR of 5.42 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in edentulous patients. The Global Dental Implants market has also been witnessing dentist collaborations with original equipment manufacturers. However, the proliferation of low-cost products could pose a …
- エスプレッソコーヒーの世界市場2019-2023About this market The increasing popularity of espresso among millennials will drive the espresso coffee market growth during the forecast period. Coffee consumption has been witnessing a considerable rise among the millennials due to increasing purchasing power. Vendors are also offering variants of espresso coffee products catering to the customization requirements of the millennial population. …
- 世界のクラウドコンピューティング開発及び商用アプリケーション市場Cloud computing continues to gain acceptance in business, enterprise and consumer markets. But can the momentum be sustained? Can current market prices remain? Will the infrastructure and security be satisfactory for the growing user base? With increased concerns over data ownership, will users remain satisfied with outsourced storage and access? We are now entering a stage of user acceptance, so …
- 創部用洗浄液の世界市場2019-2023About Wound Irrigation Wound irrigation refers to the application of a steady flow of a solution over an open wound surface to hydrate it, remove cellular debris and wound exudates, and prevent infection. Technavio’s analysts forecast the Global Wound Irrigation Solution Market to grow at a CAGR of 3.31% during the period 2019-2023. Covered in this report The report covers the present scenario and …
- 世界の光ファイバーテスト装置(FOTE)市場(2014-2018)About FOTE Fiber optic test equipment or FOTE is a type of electronic-optical instrument. It is a combination of a laser source and a detector and is used to characterize optical fiber. FOTE accesses only one end of the fiber and makes multiple measurements that are used to reveal defects and faults. It also determines the amount of signal loss at any point in the single optical fiber or complete …